The Relative Strength (RS) Rating for CRH climbed into a new percentile Wednesday, with an increase from 77 to 82.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary rating measures share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating in the early stages of their moves.
CRH has risen more than 5% past a 96.95 entry in a first-stage cup with handle, meaning it's now out of a proper buy zone. Look for the stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Top and bottom line growth moved higher in the company's most recent quarter. Earnings were up 3%, compared to 0% in the prior report. Revenue increased from 3% to 6%.
The company holds the No. 4 rank among its peers in the Building-Cement/Concrete/Aggregates industry group. Smith-Midland is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
